Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
Clinical trial NCT02739633 · UNKNOWN
Trial details
- NCT number
- NCT02739633
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.